HOME >> MEDICINE >> NEWS
Acrux reports progress in development of Testosterone MD-Lotion(R) for men

Acrux Limited (ASX: ACR), the Australian pharmaceutical company which specialises in administering drugs through the skin, today announced positive results from two more clinical studies of its Testosterone MD-Lotion treatment for testosterone deficiency in men, which is associated with a number of symptoms including lethargy, depression and reduced libido. Both studies were conducted at the Centre for Clinical Studies, Melbourne, with Professor Susan Davis supervising as Principal Investigator.

The studies compared blood levels of testosterone in healthy volunteers. The aim of the first study was to compare two different formulations of Testosterone MD Lotion, and the aim of the second study was to compare two different application sites.

The results of the first study showed that both formulations provided similar blood levels, providing options for continued development of either formulation. In the second study, there was a significant difference in absorption between the two different application sites, providing important information for the design of the remaining clinical studies in men.

In both studies, the lotion was well tolerated, with no application site reactions noted, and no serious adverse events recorded. Full details of the studies are presented in Appendix 1.

Acrux's development of Testosterone MD Lotion is continuing, with further studies to commence shortly to confirm the doses required to maintain testosterone blood levels in the target range for effective treatment.

Acrux CEO and Managing Director, Dr Igor Gonda said: "We believe our fast drying, no-touch metered dose lotion has significant competitive advantage over the existing products in this growing market. The remaining trials suit our expertise and require moderate investment, so in line with our financial plans we intend to complete them ourselves before choosing the best option for sales and marketing".

The remaining development prog
'"/>

Contact: Igor Gonda
61-383-790-100
Research Australia
7-Sep-2005


Page: 1 2

Related medicine news :

1. Acrux completes enrollment in key phase 2 trial
2. Acrux and Oreganon further expand their collaboration
3. Acrux granted first grant in Europe, triggering payment from Lilly
4. Acrux patent portfolio advances in USA
5. Acrux acquires rights to commercialise worlds first contraceptive spray
6. Four new us patents granted to Acrux for transdermal drug delivery
7. New study reports hotel guests at risk from carbon monoxide poisoning
8. MIT reports key pathway in synaptic plasticity
9. ENDEAVOR III Trial reports key findings on new-generation stent
10. New study reports improved treatment and reduced mortality for patients with heart failure
11. Study reports changing to a low-fat diet can induce stress

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... ... August 31, 2020 , ... Dr. Chang ... persons with autism and other developmental disabilities, as well as supporting staff in ... adolescents with autism, school consultation, and staff development. She joined the company in ...
(Date:8/28/2020)... ... August 28, 2020 , ... ... CEO Craig Mandeville was named an Entrepreneur Of The Year® 2020 Florida Award ... entrepreneurial business leaders whose ambitions deliver innovation, growth and prosperity as they build ...
(Date:8/28/2020)... (PRWEB) , ... August 28, 2020 , ... ... The Nourished Group set out to continue helping the specialty-diet community connect ... discover new gluten-free products, get coupons, enter giveaways, chat with brands & watch ...
(Date:8/28/2020)... ... August 28, 2020 , ... A July 27 ... individuals are at an increased risk of developing severe COVID-19 symptoms. The article ... however, because the same organ systems that the coronavirus attacks are already suffering ...
(Date:8/27/2020)... ... 2020 , ... Evolution Labs announced today that Florida Virtual ... Suite360:Mental Health and Prevention, a program developed to help students navigate a range ... Florida schools and districts must provide their students with preventative lessons after recent ...
Breaking Medicine News(10 mins):
(Date:9/2/2020)... ... September 02, 2020 , ... Rigaku Analytical Devices , ... among industry professionals about successes and challenges of making changes to their organizations’ ... and will take place on October 15, 2020 at 10:00am PDT / ...
(Date:9/1/2020)... ... September 01, 2020 , ... Mara C. ... Laser Surgery at the University of Rochester Medical Center, in Upstate New York. ... in Boston, with clinical faculty from the Harvard and Yale Departments of Dermatology ...
(Date:9/1/2020)... ... September 01, 2020 , ... September is National Ovarian Cancer ... more deaths than any other cancer of the female reproductive system. The American ... cancer and about 14,000 women will die from this disease. Throughout the month ...
Breaking Medicine Technology:
Cached News: